Medical Costs Associated with High/Moderate/Low Likelihood of Adult Growth Hormone Deficiency: A Healthcare Claims Database Analysis

References

• Yuen KCJ, Biller BMK, Radovick S, et al. American association of clinical endocrinologists and American college of endocrinology guidelines for management of growth hormone deficiency in adults and patients transitioning from pediatric to adult care. Endocr Pract. 2019;25(11):1191–1232. doi:10.4158/GL-2019-0405
   PubMed Web of Science ®Google Scholar
• Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Vance ML. Evaluation and treatment of adult growth hormone deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(6):1587–1609. doi:10.1210/jc.2011-0179
   PubMed Web of Science ®Google Scholar
• Boguszewski CL. Update on GH therapy in adults. F1000Research. 2017;6:2017. doi:10.12688/f1000research.12057.1
   PubMedGoogle Scholar
• Lam KSLS, K. MM, Tam SCF, Ng MMT, Ma HTG. Hypopituitarism after tuberculous meningitis in childhood. Ann Internal Med. 1993;118(9):701–706. doi:10.7326/0003-4819-118-9-199305010-00007
   PubMed Web of Science ®Google Scholar
• Stochholm K, Laursen T, Green A, et al. Morbidity and GH deficiency: a nationwide study. Eur J Endocrinol. 2008;158(4):447–457. doi:10.1530/EJE-07-0523
   PubMed Web of Science ®Google Scholar
• Thomas JD, Monson JP. Adult GH deficiency throughout lifetime. Eur J Endocrinol. 2009;161 (Suppl 1):S97–S106. doi:10.1530/EJE-09-0258
   PubMedGoogle Scholar
• Gupta V. Adult growth hormone deficiency. Indian J Endocrinol Metab. 2011;15(Suppl 3):S197–202. doi:10.4103/2230-8210.84865
   PubMedGoogle Scholar
• Hazem A, Elamin MB, Bancos I, et al. Therapy in endocrine disease: body composition and quality of life in adults treated with GH therapy: a systematic review and meta-analysis. Eur J Endocrinol. 2012;166(1):13–20. doi:10.1530/EJE-11-0558
   PubMed Web of Science ®Google Scholar
• Fukuda I, Hizuka N, Muraoka T, Ichihara A. Adult growth hormone deficiency: current concepts. Neurol Med Chir. 2014;54(8):599–605. doi:10.2176/nmc.ra.2014-0088
   Web of Science ®Google Scholar
• McGauley GA, Cuneo RC, Salomon F, Sönksen PH. Psychological well-being before and after growth hormone treatment in adults with growth hormone deficiency. Horm Res. 1990;33(Suppl 4):52–54. doi:10.1159/000181584
   PubMedGoogle Scholar
• Tritos NA, Biller BMK. Current concepts of the diagnosis of adult growth hormone deficiency. Rev Endocr Metab Disord. 2021;22(1):109–116. doi:10.1007/s11154-020-09594-1
   PubMed Web of Science ®Google Scholar
• Stochholm K, Gravholt CH, Laursen T, et al. Incidence of GH deficiency - A nationwide study. Eur J Endocrinol. 2006;155(1):61–71. doi:10.1530/eje.1.02191
   PubMed Web of Science ®Google Scholar
• Nedjatian N, den Hollander B, Amirouche Y. Country-specific differences in adult growth hormone deficiency diagnosis and treatment rates. 22nd European Congress of Endocrinology; 2020; Online.
   Google Scholar
• Reed ML, Merriam GR, Kargi AY. Adult growth hormone deficiency - benefits, side effects, and risks of growth hormone replacement. Front Endocrinol. 2013;4:64. doi:10.3389/fendo.2013.00064
   PubMedGoogle Scholar
• Feldt-Rasmussen U, Klose M, et al. Adult growth hormone deficiency clinical management. In: Feingold KR, Anawalt B, Boyce A, editors. Endotext. South Dartmouth (MA): MDText.com, Inc.; 2000.
   Google Scholar
• Yuen KCJ. Adult growth hormone deficiency guidelines: more difficult than it seems to incorporate into clinical practice universally. Eur J Endocrinol. 2021;184(4):C5–7. doi:10.1530/EJE-20-1455
   PubMed Web of Science ®Google Scholar
• Martel-Duguech LM, Jorgensen JOL, Korbonits M, et al. ESE audit on management of adult growth hormone deficiency in clinical practice. Eur J Endocrinol. 2020. doi:10.1530/EJE-20-1180
   PubMed Web of Science ®Google Scholar
• Yuen KCJ, Birkegard AC, Blevins LS, et al. Development of a novel algorithm to identify people with high likelihood of adult growth hormone deficiency in a US healthcare claims database. Int J Endocrinol. 2022;2022:1–9. doi:10.1155/2022/7853786
   Web of Science ®Google Scholar
• Fleseriu M, Hashim IA, Karavitaki N, et al. Hormonal replacement in hypopituitarism in adults: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(11):3888–3921. doi:10.1210/jc.2016-2118
   PubMed Web of Science ®Google Scholar
• Hernberg-Ståhl E, Luger A, Abs R, et al. Healthcare consumption decreases in parallel with improvements in quality of life during GH replacement in hypopituitary adults with GH deficiency. J Clin Endocrinol Metab. 2001;86(11):5277–5281. doi:10.1210/jcem.86.11.7997
   PubMed Web of Science ®Google Scholar
• Saller B, Mattsson AF, Kann PH, et al. Healthcare utilization, quality of life and patient-reported outcomes during two years of GH replacement therapy in GH-deficient adults - comparison between Sweden, The Netherlands and Germany. Eur J Endocrinol. 2006;154(6):843–850. doi:10.1530/eje.1.02149
   PubMed Web of Science ®Google Scholar
• Koltowska-Häggström M, Mattsson AF, Shalet SM. Assessment of quality of life in adult patients with GH deficiency: KIMS contribution to clinical practice and pharmacoeconomic evaluations. Eur J Endocrinol. 2009;161(Suppl 1):S51–64. doi:10.1530/EJE-09-0266
   PubMedGoogle Scholar
• Holmer H, Svensson J, Rylander L, et al. Psychosocial health and levels of employment in 851 hypopituitary Swedish patients on long-term GH therapy. Psychoneuroendocrinology. 2013;38(6):842–852. doi:10.1016/j.psyneuen.2012.09.008
   PubMed Web of Science ®Google Scholar
• Loftus J, Camacho-Hubner C, Hey-Hadavi J, Goodrich K. Targeted literature review of the humanistic and economic burden of adult growth hormone deficiency. Curr Med Res Opin. 2019;35(6):963–973. doi:10.1080/03007995.2018.1546682
   PubMed Web of Science ®Google Scholar
• Broder MS, Neary MP, Chang E, Cherepanov D, Ludlam WH. Burden of illness, annual healthcare utilization, and costs associated with commercially insured patients with Cushing disease in the United States. Endocr Pract. 2015;21(1):77–86. doi:10.4158/EP14126.OR
   PubMed Web of Science ®Google Scholar
• Parasher AK, Lerner DK, Glicksman JT, et al. Drivers of in-hospital costs following endoscopic transphenoidal pituitary surgery. Laryngoscope. 2021;131(4):760–764. doi:10.1002/lary.29041
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence (NICE). Human growth hormone (somatropin) in adults with growth hormone deficiency [TA64]; 2003. Available from: https://www.nice.org.uk/guidance/TA64. Accessed April 05, 2023.
   Google Scholar
• Bolin K, Sandin R, Koltowska-Häggström M, Loftus J, Prütz C, Jonsson B. The cost-effectiveness of growth hormone replacement therapy (Genotropin®) in hypopituitary adults in Sweden. Cost Eff Resour Alloc. 2013;11(1):24. doi:10.1186/1478-7547-11-24
   PubMedGoogle Scholar
• Austin PC. Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research. Commun Stat Simul Comput. 2009;38(6–7):1228–1234. doi:10.1080/03610910902859574
   Web of Science ®Google Scholar
• Cortaredona S, Ventelou B. The extra cost of comorbidity: multiple illnesses and the economic burden of non-communicable diseases. BMC Med. 2017;15(1):216. doi:10.1186/s12916-017-0978-2
   PubMedGoogle Scholar
• National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP). Health and Economic Costs of Chronic Diseases; 2022. Available from: https://www.cdc.gov/chronicdisease/about/costs/index.htm. Accessed July 06, 2022.
   Google Scholar
• Owens GM. Gender differences in health care expenditures, resource utilization, and quality of care. J Manag Care Pharm. 2008;14(3 Suppl):2–6. doi:10.18553/jmcp.2008.14.S6-A.2
   PubMed Web of Science ®Google Scholar
• Cameron KA, Song J, Manheim LM, Dunlop DD. Gender disparities in health and healthcare use among older adults. J Womens Health (Larchmt). 2010;19(9):1643–1650. doi:10.1089/jwh.2009.1701
   PubMed Web of Science ®Google Scholar
• Henry J Kaiser Family Foundation. Medicaid’s role for women; 2019. Available from: https://firstfocus.org/wp-content/uploads/2019/11/Fact-Sheet-Medicaids-Role-for-Women.pdf. Accessed April 05, 2023.
   Google Scholar
• Spiliotis BE. Growth hormone insufficiency and its impact on ovarian function. Ann N Y Acad Sci. 2003;997:77–84. doi:10.1196/annals.1290.009
   PubMed Web of Science ®Google Scholar
• Kilgore M, Patel HK, Kielhorn A, Maya JF, Sharma P. Economic burden of hospitalizations of medicare beneficiaries with heart failure. Risk Manag Healthc Policy. 2017;10:63–70. doi:10.2147/RMHP.S130341
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Economic costs of diabetes in the U.S. in 2017. Diabetes Care. 2018;41(5):917–928. doi:10.2337/dci18-0007
   PubMed Web of Science ®Google Scholar
• Höybye C, Sävendahl L, Christesen HT, et al. The NordiNet® International Outcome Study and NovoNet® ANSWER Program®: rationale, design, and methodology of two international pharmacoepidemiological registry-based studies monitoring long-term clinical and safety outcomes of growth hormone therapy (Norditropin®). Clin Epidemiol. 2013;5:119–127. doi:10.2147/CLEP.S42602
   PubMedGoogle Scholar
• Gutiérrez LP, Kołtowska-Häggström M, Jönsson PJ, et al. Registries as a tool in evidence-based medicine: example of KIMS (Pfizer International Metabolic Database). Pharmacoepidemiol Drug Saf. 2008;17(1):90–102. doi:10.1002/pds.1510
   PubMed Web of Science ®Google Scholar
• Kulaylat AS, Schaefer EW, Messaris E, Hollenbeak CS. Truven Health Analytics MarketScan databases for clinical research in colon and rectal surgery. Clin Colon Rectal Surg. 2019;32(1):54–60. doi:10.1055/s-0038-1673354
   PubMed Web of Science ®Google Scholar